2005

Company Will Promptly and Fully Respond to FDA Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today that it has received a warning letter from the U.S. Food and Drug Administration...

SPIRIT III U.S. Randomized Enrollment Passes Halfway Mark Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has begun enrollment in the Japan arm of its SPIRIT...

Advanced Lead is Designed to Enable Physicians to Overcome Challenging Left Ventricular Anatomy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced Conformité...

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that its Board of Directors has made the requisite determination under Guidant's merger agreement with Johnson & Johnson to...

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) acknowledges receipt of a letter dated today, , outlining a proposed transaction with Boston Scientific. Guidant's Board of Directors will...

Ronald W. Dollens Retires after 11 Years as CEO; Special Shareholder Meeting Anticipated in January Indianapolis, Ind. - In a joint press release issued earlier today, Guidant Corporation (NYSE:...

Results Demonstrate Sustained Benefit of the XIENCE V Everolimus Eluting Coronary Stent System Indianapolis, Ind., and Dallas, Texas - Guidant Corporation (NYSE: GDT) today announced 12-month...

Data from Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...

Cardiac Rhythm Management Report Delivers Unprecedented Level of Information Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) announced today the easy availability of even more detailed...

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a fourth quarter dividend of $0.10 per share on outstanding common stock. This...